CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −6,818 | $20.16 | $137K | 285,138 |
| 2020-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −2,014 | $20.16 | $41K | 283,124 |
| 2020-11-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −1,573 | $20.16 | $32K | 472,942 |
| 2020-11-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −6,557 | $20.16 | $132K | 466,385 |
| 2020-11-15 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −2,131 | $20.16 | $43K | 464,254 |
| 2020-11-15 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion | +30,000 | $7.27 | $218K | 494,254 |
| 2020-11-15 | Hessekiel Jeffrey EVP and General Counsel | Exercise or conversion · Option (right to buy) | −30,000 | 30,000 | ||
| 2020-11-15 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Shares withheld for taxes | −2,685 | $20.16 | $54K | 489,667 |
| 2020-11-15 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Shares withheld for taxes | −9,685 | $20.16 | $195K | 479,982 |
| 2020-11-15 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Shares withheld for taxes | −2,583 | $20.16 | $52K | 477,399 |
| 2020-11-10 | WYSZOMIERSKI JACK L Director | Exercise or conversion | +62,403 | $5.82 | $363K | 231,809 |
| 2020-11-10 | WYSZOMIERSKI JACK L Director | Sale | −34,000 | $20.61 | $701K | 197,809 |
| 2020-11-10 | WYSZOMIERSKI JACK L Director | Exercise or conversion · Option (right to buy) | −62,403 | 0 | ||
| 2020-10-22 | MORRISSEY MICHAEL President and CEO | Grant or award | +672,861 | 775,966 | ||
| 2020-10-22 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −177,132 | $21.79 | $3.9M | 598,834 |
| 2020-10-22 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Grant or award | +213,879 | 547,070 | ||
| 2020-10-22 | Schwab Gisela Pres, Prod Dev & Med Aff & CMO | Shares withheld for taxes | −55,235 | $21.79 | $1.2M | 491,835 |
| 2020-10-22 | Haley Patrick J. EVP, Commercial | Grant or award | +178,231 | 293,802 | ||
| 2020-10-22 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −44,184 | $21.79 | $963K | 249,618 |
| 2020-10-22 | Hessekiel Jeffrey EVP and General Counsel | Grant or award | +178,231 | 521,257 |
Page 39 of 42 · 836 trades